Maternal Diseases Complicating Pregnancy: Diabetes, Tumors, Preeclampsia, Lupus Anticoagulant | SpringerLink
Pre-eclampsia - Wikipedia
Präeklampsie: Screening und Diagnostik mit neuen Marker- Kombinationen – Rosenfluh.ch
The kidney in preeclampsia - Kidney International
HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy - American Journal of Obstetrics & Gynecology
Review: Where is the maternofetal interface? - ScienceDirect
References in Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child - American Journal of Obstetrics & Gynecology
Overview and recent developments in cell‐based noninvasive prenatal testing - Vossaert - 2021 - Prenatal Diagnosis - Wiley Online Library
Gesundheitslexikon: Eklampsie
Fetal nucleated erythrocyte recovery: Fluorescence activated cell sorting‐based positive selection using anti‐gamma globin versus magnetic activated cell sorting using anti‐CD45 depletion and anti‐gamma globin positive selection - Wang - 2000 - Cytometry -
Eklampsie und HELLP−Syndrom
Integrins mediate placental extracellular vesicle trafficking to lung and liver in vivo | Scientific Reports
Overview and recent developments in cell‐based noninvasive prenatal testing - Vossaert - 2021 - Prenatal Diagnosis - Wiley Online Library
Review: Where is the maternofetal interface? - ScienceDirect
Cells | Free Full-Text | Melatonin, a Potential Therapeutic Agent for Preeclampsia, Reduces the Extrusion of Toxic Extracellular Vesicles from Preeclamptic Placentae | HTML
Antiphospholipid antibodies and extracellular vesicles in pregnancy - Tong - 2021 - American Journal of Reproductive Immunology - Wiley Online Library
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine | Hypertension
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine | Hypertension
Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? - ScienceDirect
PDF) Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
Cells | Free Full-Text | The Role of Non-Coding RNAs in the Human Placenta | HTML
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates | Nature Reviews Immunology
J Carlsson's research works | Linnaeus University, Växjö (lnu) and other places
Cell dynamics in human villous trophoblast
PPT – PREEKLAMPSIE, EKLAMPSIE, HELLP SYNDROM PowerPoint presentation | free to view - id: 705fe4-YTc3O
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine | Hypertension
Cells | Free Full-Text | Melatonin, a Potential Therapeutic Agent for Preeclampsia, Reduces the Extrusion of Toxic Extracellular Vesicles from Preeclamptic Placentae | HTML
